Matches in Nanopublications for { ?s ?p "[CSF levels of PECAM-1 and sPECAM-1 are increased in patients in active stages of multiple sclerosis.[ review]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP119974.RAkCCESW0h3i4DAdOZSVdR0QcMMK4FtxU7Z2IB8UATJUs130_assertion description "[CSF levels of PECAM-1 and sPECAM-1 are increased in patients in active stages of multiple sclerosis.[ review]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119974.RAkCCESW0h3i4DAdOZSVdR0QcMMK4FtxU7Z2IB8UATJUs130_provenance.
- NP183167.RALKo1_fSXsiDYl5dGVuSzeWvLNt5F4yS0HDHbZi4V9zE130_assertion description "[CSF levels of PECAM-1 and sPECAM-1 are increased in patients in active stages of multiple sclerosis.[ review]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183167.RALKo1_fSXsiDYl5dGVuSzeWvLNt5F4yS0HDHbZi4V9zE130_provenance.
- NP220944.RAIj6uFuNkKiOpDIUVcdIatQFFdE_dP9l70SKaNC9du5s130_assertion description "[CSF levels of PECAM-1 and sPECAM-1 are increased in patients in active stages of multiple sclerosis.[ review]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220944.RAIj6uFuNkKiOpDIUVcdIatQFFdE_dP9l70SKaNC9du5s130_provenance.